Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Robin M Ciocca"'
Publikováno v:
LGBT Health
Purpose: Sexual minority women (SMW) may have a different distribution of breast cancer risk factors than their heterosexual peers. Epidemiologic studies of breast cancer in SMW have been limited, and many use only proxy variables to identify SMW in
Autor:
Austin D, Williams, Meghan, Buckley, Robin M, Ciocca, Jennifer L, Sabol, Sharon L, Larson, Ned Z, Carp
Publikováno v:
Breast cancer research and treatment. 192(1)
Many studies have demonstrated disparities in breast cancer (BC) incidence and mortality among Black women. We hypothesized that in Pennsylvania (PA), a large economically diverse state, BC diagnosis and mortality would be similar among races when st
Autor:
Margaretha Wallon, Jonah D Klein, Zachary Aukers, Nolan Metz, Vibha Ahudja, Laura Mandik-Nayak, Vincenzo Ciocca, Vlasta Zemba-Palko, Robin M Ciocca, Jennifer L Sabol, Ned Z Carp
Publikováno v:
Cancer Research. 82:P4-04
Background: Breast cancers are traditionally viewed as immunologically silent. However, recent research has demonstrated that the triple-negative breast cancer (TNBC) and HER-2 positive (HER2) are capable of stimulating the immune system. In contrast
Autor:
Jennifer L Sabol, Ned Z. Carp, UM Wallon, Z Aukers, John James Kennedy, Robin M Ciocca, Jonah D. Klein
Publikováno v:
Cancer Research. 79:P4-06
Background: Breast cancer is traditionally not considered as a highly immunogenic disease. Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with reported high genomic instability and high mutation rate, indicating the possi
Publikováno v:
Annals of Surgical Oncology. 28:601-601
Publikováno v:
Journal of the American College of Surgeons. 231:S40
Autor:
Jennifer L Sabol, Vlasta Zemba-Palko, Margaretha Wallon, Jonah D. Klein, Vincenzo Ciocca, Allison A Campoverde, John James Kennedy, Robin M Ciocca, Zachary Aukers, Ned Z. Carp
Publikováno v:
Cancer Research. 80:P5-04
Background: Cryoablation, the destruction of cells by ultra-low temperatures, has been used to treat benign breast disease and two clinical trials (ACOSOG Z1072 and FROST) have been conducted to determine its utility in invasive breast cancers. The f
Autor:
George C. Prendergast, Zonera A. Ali, Ned Z. Carp, Vlasta Zemba-Palko, Jennifer L Sabol, U. Margaretha Wallon, Robin M Ciocca, Paul B. Gilman, James S DuHadaway, Erica Sutanto-Ward
Publikováno v:
Cancer Research. 75:P6-08
BACKGROUND – Tissue inhibitor of metalloproteinase-4 (TIMP-4) is a secreted multi-functional protein associated with poor survival prognosis among early-stage triple-negative breast cancers (TNBC). TNBC represent a highly aggressive form of this di
Autor:
Robin M Ciocca, Vlasta Zemba-Palko, George C. Prendergast, Jennifer L Sabol, UM Wallon, Ned Z. Carp, BS Wojciechowski
Publikováno v:
Cancer Research. 71:P4-09
BACKGROUND: Triple-negative breast cancers (TNBC) represent a highly aggressive form of this disease with few treatment options available. Currently, even the smallest node negative cancers are considered by many to warrant treatment with chemotherap
Autor:
Constantine Daskalakis, Robin M. Ciocca, Juan P. Palazzo, Vincenzo Ciocca, Alejandra Ruiz-Orrico
Publikováno v:
Human Pathology. 40:489-495
GATA3 is a transcription factor closely associated with estrogen receptor alpha in breast carcinoma, with a potential prognostic utility. This study investigated the immunohistochemical expression of GATA3 in estrogen receptor alpha-positive and estr